NEW YORK (GenomeWeb News) – Leerink Swann analyst Isaac Ro today lowered the bank's estimates and valuation on Illumina.

He lowered the estimate on Illumina's 2010 earnings per share to $1.03 from his previous estimate of $1.18, based on the assumption that the firm's R&D and SG&A spending will increase.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.